Home / 2011 / November (page 3)

Monthly Archives: November 2011

Editor’s Note: “Schiff base” and AGEs

Some of you may remember the term “Schiff base” from your days in the chemistry lab, but do you have any idea what this compound has to do with diabetes? When it comes to advanced glycation end products (AGEs), a Schiff base is what contributes to the overall damage. This …

Read More »

Overview of AGEs, Part 1 of 4

DCMS_HS_60

This week we begin a new Homerun Slides series on advanced glycation end-products (AGEs) focusing on gaining insight into understanding the formation of  (AGEs), their overall impact on diabetic patients, and ways to reduce or negate their effect.

Read More »

GLP-1’s Function in Preserving B-cells

GLP1sFunctioninPreservingBCells-Image

Associations between acute glucose lowering and improved acute insulin secretory responses suggest improved β-cell function. Comparing and assessing effects of pharmacological therapies used to control hyperglycemia on β-cell function is necessarily inferential, given lack of any universal measure.1

Read More »

Formula for Converting A1c to eAG

eAG

Formula for Converting A1c to eAG  Converting your patients A1c result to their average blood glucose will give them a better understanding of their diabetes control. Most patients do not have a true understanding of what their A1c result means to their overall health. By converting their A1c to their …

Read More »

tSlim Insulin Pump

tslim

tSlim Insulin Pump An insulin pump that’s sized like a credit card, Tandem Diabetes Care’s t:slim™ Insulin Delivery System is today’s slimmest insulin pump — up to 25% slimmer than others. Through an easy-to-use touch screen, entering important information and accessing features is accomplished with fewer button-pressing steps. The t:slim insulin …

Read More »